thymopentin has been researched along with Hematologic Malignancies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, LL; Chi, XH; Dai, HR; Han, WD; Liu, Y; Lu, XC; Wang, Y; Yang, B; Yu, RL; Zhu, HL | 1 |
1 trial(s) available for thymopentin and Hematologic Malignancies
| Article | Year |
|---|---|
Repeated transfusions of autologous cytokine-induced killer cells for treatment of haematological malignancies in elderly patients: a pilot clinical trial.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; beta 2-Microglobulin; Biomarkers, Tumor; Cells, Cultured; Comorbidity; Cytokine-Induced Killer Cells; Female; Hematologic Neoplasms; Humans; Immunotherapy, Adoptive; Interferon-gamma; Interleukin-2; L-Lactate Dehydrogenase; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Myelodysplastic Syndromes; Pilot Projects; Recombinant Proteins; Remission Induction; Salvage Therapy; Thymopentin; Treatment Outcome | 2012 |